NCT05551793View on ClinicalTrials.gov

Regeneron AA Multicenter (Dupilumab)

PHASE2RecruitingINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

April 10, 2023

Primary Completion Date

November 3, 2027

Study Completion Date

November 3, 2027

Conditions
Alopecia Areata
Interventions
DRUG

Dupilumab

Dupilumab: 300mg SC injections

DRUG

Placebo

Placebo: SC injections of equivalent volume

Trial Locations (3)

10029

RECRUITING

Icahn School of Medicine at Mount Sinai, New York

14620

RECRUITING

UR Dermatology at College Town, Rochester

92697

RECRUITING

University of California, Irvine, Irvine

All Listed Sponsors
collaborator

Regeneron Pharmaceuticals

INDUSTRY

lead

Emma Guttman

OTHER